Literature DB >> 8308973

Transdermal clonidine for ameliorating post-orchiectomy hot flashes.

C L Loprinzi1, R M Goldberg, J R O'Fallon, S K Quella, A W Miser, L A Mynderse, L D Brown, L K Tschetter, M B Wilwerding, M Dose.   

Abstract

To determine the efficacy of transdermal clonidine for alleviating post-orchiectomy hot flashes, a randomized, double-blind, crossover clinical trial was designed including 70 men with a history of prostate cancer who had undergone a medical or surgical orchiectomy and were suffering from hot flashes. The results of this study demonstrated that clonidine did not significantly decrease hot flash frequency or severity. Future research is necessary to find effective means of alleviating hot flashes in post-orchiectomy patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8308973     DOI: 10.1016/s0022-5347(17)35034-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

Review 1.  Androgen deprivation therapy-associated vasomotor symptoms.

Authors:  Jason M Jones; Manish Kohli; Charles L Loprinzi
Journal:  Asian J Androl       Date:  2012-01-30       Impact factor: 3.285

2.  Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.

Authors:  Gary Elkins; Joel Marcus; Vered Stearns; Michelle Perfect; M Hasan Rajab; Christopher Ruud; Lynne Palamara; Timothy Keith
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

3.  Feasibility study of acupuncture for reducing sleep disturbances and hot flashes in postmenopausal breast cancer survivors.

Authors:  Julie L Otte; Janet S Carpenter; Xin Zhong; Peter A S Johnstone
Journal:  Clin Nurse Spec       Date:  2011 Sep-Oct       Impact factor: 1.067

4.  Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

Authors:  Amanda R Moraska; Pamela J Atherton; Daniel W Szydlo; Debra L Barton; Philip J Stella; Kendrith M Rowland; Paul L Schaefer; James Krook; James D Bearden; Charles L Loprinzi
Journal:  J Support Oncol       Date:  2010 May-Jun

5.  MODERATING EFFECT OF HYPNOTIZABILITY ON HYPNOSIS FOR HOT FLASHES IN BREAST CANCER SURVIVORS.

Authors:  Gary Elkins; William Fisher; Aimee Johnson; Joel Marcus; Jacqueline Dove; Michelle Perfect; Timothy Keith
Journal:  Contemp Hypn Integr Ther       Date:  2011-09-01

Review 6.  Risk factors, pathophysiology, and treatment of hot flashes in cancer.

Authors:  William I Fisher; Aimee K Johnson; Gary R Elkins; Julie L Otte; Debra S Burns; Menggang Yu; Janet S Carpenter
Journal:  CA Cancer J Clin       Date:  2013-01-25       Impact factor: 508.702

7.  Estrogenic side effects of androgen deprivation therapy.

Authors:  Theresa A Guise; Michael G Oefelein; James A Eastham; Michael S Cookson; Celestia S Higano; Matthew Raymond Smith
Journal:  Rev Urol       Date:  2007

Review 8.  North Central Cancer Treatment Group--achievements and perspectives.

Authors:  Axel Grothey; Alex A Adjei; Steve R Alberts; Edith A Perez; Kurt A Jaeckle; Charles L Loprinzi; Daniel J Sargent; Jeff A Sloan; Jan C Buckner
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929

9.  A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).

Authors:  C L Loprinzi; A C Dueck; B S Khoyratty; D L Barton; S Jafar; K M Rowland; P J Atherton; G W Marsa; W H Knutson; J D Bearden; L Kottschade; T R Fitch
Journal:  Ann Oncol       Date:  2009-01-06       Impact factor: 32.976

Review 10.  Complications of androgen deprivation therapy in men with prostate cancer.

Authors:  Allen C Chen; Daniel P Petrylak
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.